Steven M Teutsch

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi A quantitative analysis of fish consumption and stroke risk
    Colleen Bouzan
    Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Am J Prev Med 29:347-52. 2005
  2. ncbi Dissecting cost-effectiveness analysis for preventive interventions: a guide for decision makers
    S M Teutsch
    Merck and Co, Inc, PA, USA
    Am J Manag Care 5:301-5. 1999
  3. ncbi Health trade-offs from policies to alter fish consumption
    Steven M Teutsch
    Merck and Co, Inc, West Point, Pennsylvania 19486-0004, USA
    Am J Prev Med 29:324. 2005
  4. ncbi Evidence synthesis and evidence-based decision making: related but distinct processes
    Steven M Teutsch
    Merck and Co, Inc, West Point, PA 19486, USA
    Med Decis Making 25:487-9. 2005
  5. ncbi Spanning the boundary between clinics and communities to address overweight and obesity in children
    Steven M Teutsch
    Outcomes Research and Management, Merck and Company, Inc, PO Box 4, WP39-130, West Point, PA 19486-0004, USA
    Pediatrics 116:240-1. 2005
  6. ncbi Comparative effectiveness: asking the right questions, choosing the right method
    Steven M Teutsch
    Merck and Company Inc, West Point, Pennsylvania, USA
    Health Aff (Millwood) 24:128-32. 2005
  7. ncbi A framework for outcomes research in cancer: response to Carolyn Clancy
    Steven M Teutsch
    Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania 19486-0004, USA
    Med Care 40:III101-3. 2002
  8. ncbi The decision to conduct a head-to-head comparative trial: a game-theoretic analysis
    Edward C Mansley
    Outcomes Research and Management, Merck and Co Inc, WP39 166, P O Box 4, West Point, PA 19486 000, USA
    Med Decis Making 27:364-79. 2007
  9. ncbi Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease
    C M Alexander
    Department of Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania, USA
    Am J Cardiol 86:897-902. 2000
  10. ncbi Burden of aspergillosis-related hospitalizations in the United States
    E J Dasbach
    Merck Research Laboratories, Blue Bell, PA 19422, USA
    Clin Infect Dis 31:1524-8. 2000

Detail Information

Publications28

  1. ncbi A quantitative analysis of fish consumption and stroke risk
    Colleen Bouzan
    Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Am J Prev Med 29:347-52. 2005
    ..0% per serving per week)...
  2. ncbi Dissecting cost-effectiveness analysis for preventive interventions: a guide for decision makers
    S M Teutsch
    Merck and Co, Inc, PA, USA
    Am J Manag Care 5:301-5. 1999
    ..Decision makers usually limit their use of economic evaluations of preventive interventions to the cost-effectiveness ratio...
  3. ncbi Health trade-offs from policies to alter fish consumption
    Steven M Teutsch
    Merck and Co, Inc, West Point, Pennsylvania 19486-0004, USA
    Am J Prev Med 29:324. 2005
  4. ncbi Evidence synthesis and evidence-based decision making: related but distinct processes
    Steven M Teutsch
    Merck and Co, Inc, West Point, PA 19486, USA
    Med Decis Making 25:487-9. 2005
  5. ncbi Spanning the boundary between clinics and communities to address overweight and obesity in children
    Steven M Teutsch
    Outcomes Research and Management, Merck and Company, Inc, PO Box 4, WP39-130, West Point, PA 19486-0004, USA
    Pediatrics 116:240-1. 2005
  6. ncbi Comparative effectiveness: asking the right questions, choosing the right method
    Steven M Teutsch
    Merck and Company Inc, West Point, Pennsylvania, USA
    Health Aff (Millwood) 24:128-32. 2005
    ..We consider the consequences of these strategies. This paper proposes a framework for using different methods to assess available evidence. We contend that choosing the appropriate method can occur only when there are clear policy goals...
  7. ncbi A framework for outcomes research in cancer: response to Carolyn Clancy
    Steven M Teutsch
    Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania 19486-0004, USA
    Med Care 40:III101-3. 2002
  8. ncbi The decision to conduct a head-to-head comparative trial: a game-theoretic analysis
    Edward C Mansley
    Outcomes Research and Management, Merck and Co Inc, WP39 166, P O Box 4, West Point, PA 19486 000, USA
    Med Decis Making 27:364-79. 2007
    ..Finally, the results indicate that incentives that offset the direct cost of a trial can prevent a no-trial equilibrium, even when both firms face the possibility of an inferior outcome...
  9. ncbi Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease
    C M Alexander
    Department of Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania, USA
    Am J Cardiol 86:897-902. 2000
    ..However, hyperglycemia, per se, does not explain the excess risk. In addition to glucose, lipid profiles and blood pressure should be periodically monitored and appropriate treatment provided to reduce morbidity and mortality from CHD...
  10. ncbi Burden of aspergillosis-related hospitalizations in the United States
    E J Dasbach
    Merck Research Laboratories, Blue Bell, PA 19422, USA
    Clin Infect Dis 31:1524-8. 2000
    ..Although aspergillosis-related hospitalizations account for a small percentage of hospitalizations in the United States, patients hospitalized with the condition have lengthy hospital stays and high mortality rates...
  11. ncbi The evidence for evidence-based public health
    Steven M Teutsch
    US Outcomes Research Merck and Co, Inc, PO Box 4, WP 39-162, West Point, PA 19486, USA. steven
    J Public Health Manag Pract 14:92-3. 2008
  12. ncbi Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization
    Pamela B Landsman
    Outcomes Research and Management, US Medical and Scientific Affairs, Merck and Company Inc, PO Box 100, UG2B 74, 351 N Sumneytown Pike, North Wales, PA 19454 2505, USA
    Am J Manag Care 11:621-8. 2005
    ..To estimate responsiveness of prescription demand within 9 therapeutic classes to increased cost-sharing compared with constant cost-sharing...
  13. ncbi The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group
    Steven M Teutsch
    Merck and Company, Inc, West Point, Pennsylvania, USA
    Genet Med 11:3-14. 2009
    ..This article describes the EGAPP processes and details the specific methods and approaches used by the EWG...
  14. ncbi Indirect cost of ischemic heart disease to employers
    C J Guico-Pabia
    Outcomes Research and Management, Merck and Co Inc, West Point, PA, USA
    Am J Manag Care 7:27-34. 2001
    ..CONCLUSION: From the perspective of the employer, the indirect cost of ischemic heart disease is overwhelmingly due to morbidity costs...
  15. ncbi Evidence-based public health policy and practice: promises and limits
    Laurie M Anderson
    Division of Scientific Communication, National Center for Health Marketing, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Am J Prev Med 28:226-30. 2005
  16. ncbi A quantitative risk-benefit analysis of changes in population fish consumption
    Joshua T Cohen
    Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Am J Prev Med 29:325-34. 2005
    ....
  17. ncbi Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review
    Roy C Baron
    Community Guide Branch, National Center for Health Marketing, CDC, Atlanta, Georgia, USA
    Am J Prev Med 35:S34-55. 2008
    ..e., flexible sigmoidoscopy, colonoscopy, double contrast barium enema). Specific areas for further research are also suggested in this report...
  18. ncbi Integrating evidence-based clinical and community strategies to improve health
    Judith K Ockene
    Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
    Am J Prev Med 32:244-52. 2007
    ....
  19. ncbi Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers
    Roy C Baron
    Community Guide Branch, National Center for Health Marketing, CDC, Atlanta, Georgia, USA
    Am J Prev Med 35:S26-33. 2008
  20. ncbi Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening a systematic review
    Roy C Baron
    Community Guide Branch, National Center for Health Marketing, CDC, Atlanta, Georgia, USA
    Am J Prev Med 35:S56-66. 2008
    ..e., flexible sigmoidoscopy, colonoscopy, double contrast barium enema). Specific areas for further research are also suggested in this report...
  21. ncbi Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement
    Diana B Petitti
    Ann Intern Med 148:759-65. 2008
    ..Recommendation: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.)...
  22. ncbi Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives
    Susan A Sabatino
    CDC Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia, USA
    Am J Prev Med 35:S67-74. 2008
    ..e., flexible sigmoidoscopy, colonoscopy, or double-contrast barium enema)...
  23. ncbi Lessons from cost-effectiveness research for United States public health policy
    Scott D Grosse
    National Center on Birth Defects and Developmental Disabilities, Coordinating Center for Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Annu Rev Public Health 28:365-91. 2007
    ..Policy makers have funded certain interventions with rather high cost-effectiveness ratios, notably nucleic acid testing for blood product safety. Cost-effectiveness estimates are a decision aid, not a decision rule...
  24. ncbi A quantitative analysis of fish consumption and coronary heart disease mortality
    Ariane König
    Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Am J Prev Med 29:335-46. 2005
    ..9%. Small quantities of fish consumption were associated with risk reductions in nonfatal MI risk by 27%, but additional fish consumption conferred no incremental benefits...
  25. ncbi Screening for overweight in children and adolescents: where is the evidence? a commentary by the childhood obesity working group of the US Preventive Services Task Force
    Virginia A Moyer
    Department of Pediatrics, University of Texas Health Science Center, Houston, TX 77030, USA
    Pediatrics 116:235-8. 2005
  26. ncbi Pharmacy benefits and the use of drugs by the chronically ill
    Dana P Goldman
    RAND, Santa Monica, Calif 90407 2138, USA
    JAMA 291:2344-50. 2004
    ..Many health plans have instituted more cost sharing to discourage use of more expensive pharmaceuticals and to reduce drug spending...
  27. ncbi Promoting informed decisions about cancer screening in communities and healthcare systems
    Peter Briss
    Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Am J Prev Med 26:67-80. 2004
    ..Finally, work is needed on the presence and magnitude of barriers to and harms of IDM interventions and how they might be avoided...
  28. ncbi Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force
    Michael Pignone
    University of North Carolina at Chapel Hill, Department of Medicine and Cecil Sheps Center for Health Services Research, 5039 Old Clinic Building, CB #7110, Chapel Hill, NC 27599, USA
    Ann Intern Med 137:132-41. 2002
    ..Several available screening options seem to be effective, but the single best screening approach cannot be determined because data are insufficient...